IN-PROCESS CONTROL IN A METHOD FOR PRODUCING EPO
    6.
    发明申请
    IN-PROCESS CONTROL IN A METHOD FOR PRODUCING EPO 审中-公开
    生产EPO的方法中的过程控制

    公开(公告)号:US20120021441A1

    公开(公告)日:2012-01-26

    申请号:US13140190

    申请日:2009-12-07

    IPC分类号: G01N33/74 G01N21/78

    CPC分类号: G01N33/746

    摘要: The invention relates to a method for determining the isoform composition of erythropoietin, comprising the following steps: a) isoelectrical focusing of a sample comprising erythropoietin in a gel over a pH range having a lower limit of 2.5 to 3.5 and an upper limit of 5 to 8, wherein the sample comprising erythropoietin originates from a culture supernatant of erythropoietin producing eukaryotic cells; b) transferring of the proteins comprised and separated in the gel to a membrane; c) verifying the erythropoietin bound to the membrane by specific antibodies; and to a method for in-process control of culture supernatants of erythropoietin producing eukaryotic cells during the fermentative production process.

    摘要翻译: 本发明涉及一种测定红细胞生成素的同种型组成的方法,包括以下步骤:a)将包含促红细胞生成素的样品在凝胶中的等电聚焦在pH范围内,其下限为2.5至3.5,上限为5至 8,其中包含促红细胞生成素的样品源自产生促红细胞生成素的真核细胞的培养上清液; b)将在凝胶中包含和分离的蛋白质转移到膜上; c)通过特异性抗体验证与该膜结合的促红细胞生成素; 以及在发酵生产过程中用于在产生促红细胞生成素的真核细胞的培养物上清液中进行过程控制的方法。

    Process for the one-stage resalting and purification of oligopeptides
    8.
    发明授权
    Process for the one-stage resalting and purification of oligopeptides 失效
    寡肽一步分离和纯化的方法

    公开(公告)号:US06258933B1

    公开(公告)日:2001-07-10

    申请号:US09276709

    申请日:1999-03-26

    IPC分类号: C07K116

    CPC分类号: C07K7/23 C07K1/122 C07K1/36

    摘要: The present invention relates to a process for the one-stage resalting and purification of oligopeptides. Oligopeptides are often not formed directly as acetates when synthesised. Acetate salts of oligopeptides are however desirable as bulk-active material for medical and formulation reasons. Processes known from the prior art have hitherto involved two separate steps or pyridine-containing solvents. The resalting and purification can be combined in one step and the use of pyridine as solvent can be avoided, if the oligopeptide in the form of its chloride salt is purified with an acetate-containing solvent by liquid chromatography methods.

    摘要翻译: 本发明涉及寡肽一步骤分离和纯化的方法。 当合成时,寡肽通常不直接形成为乙酸酯。 然而,寡肽的乙酸盐作为用于医学和制剂原因的体积活性材料是理想的。 已知现有技术的方法迄今涉及两个独立的步骤或含吡啶的溶剂。 如果用含有乙酸酯的溶剂通过液相色谱法纯化其氯化物盐形式的寡肽,则可以将脱盐和纯化结合在一个步骤中,并且可以避免使用吡啶作为溶剂。